Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thymocyte-expressed positive selection-associated protein 1 (TESPA1) is a scaffold/adaptor protein highly expressed in developing thymocytes, peripheral T cells, and B cells. It is crucial for the positive selection and maturation of T cells in the thymus, acting as a regulator of T cell receptor (TCR) signaling. TESPA1 achieves this by binding to key signaling molecules including PLCγ1 and the inositol 1,4,5-trisphosphate receptor (IP3R), thereby facilitating TCR-triggered intracellular calcium mobilization and downstream signaling required for T cell development. It has additional roles in stabilizing TRAF6, influencing PLCγ2 phosphorylation in B cells, and modulating mast cell-mediated allergic responses. However, disruption of TESPA1 affects T cell development much more than peripheral immune responses, marking it as a stage-specific regulator within the immune system. TESPA1 is not currently targeted by approved or investigational drugs
Not applicable (no drugs targeting TESPA1)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thymocyte-expressed positive selection-associated protein 1 (TESPA1).